Dr. Ganatra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
41 Mall Rd
Burlington, MA 01805Phone+1 781-744-8460Fax+1 781-272-5261
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2018 - 2019
- Lahey ClinicFellowship, Cardiovascular Disease, 2015 - 2018
- Lahey ClinicChief Residency, Internal Medicine, 2014 - 2015
- Lahey ClinicResidency, Internal Medicine, 2011 - 2014
- N.H.L Municipal Medical CollegeClass of 2009
Certifications & Licensure
- MA State Medical License 2013 - 2026
- NH State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 23 citationsCardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week.Sonu Abraham, Anju Nohria, Tomas G Neilan, Aarti Asnani, Anu Mariam Saji
Journal of the American College of Cardiology. 2022-11-15 - 17 citationsNiacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study.Nathan H Raines, Sarju Ganatra, Pitchaphon Nissaisorakarn, Amar Pandit, Alex Morales
Kidney360. 2021-01-28 - 940 citationsMYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORSSyed S. Mahmood, Michael G. Fradley, Justine V. Cohen, Anju Nohria, Kerry L. Reynolds
Journal of the American College of Cardiology. 2018-04-24
Journal Articles
- Immune Checkpoint Inhibitor‐Associated MyocarditisSarju Ganatra, MD, The Oncologist
Authored Content
- COVID-19 in Cardio-Oncology PopulationJanuary 2021
Press Mentions
- Mass. Doctors Combat 'Devastating' Trend of Heart Disease in South Asian PatientsOctober 30th, 2024
- Warning: Popular COVID-19 Drug May Interact with Common Heart MedicationsNovember 20th, 2022
- COVID-19 Drug Paxlovid May React Poorly with Certain Heart Medications, Cardiologists WarnOctober 19th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Gujarati, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: